Publications by authors named "Aggeliki Pandi"

Claim this Profile
S
Structured narrative review on lung cancer screening: current evidence, clinical practice implications and implementation insights from a multidisciplinary task force and patient representatives.
Georgia Hardavella, Kyriaki Tavernaraki, Dimitrios Lioumpas, Efimia Boutsikou, Eleni Karetsi, Aggeliki Pandi

Eur Respir Rev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Theodoros Karampitsakos, Vasilina Sotiropoulou, Matthaios Katsaras, Panagiota Tsiri, Vasiliki E Georgakopoulou, Aggeliki Pandi

Front Med (Lausanne)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model.
Theodoros Karampitsakos, Vasilina Sotiropoulou, Matthaios Katsaras, Panagiota Tsiri, Vasiliki E Georgakopoulou, Aggeliki Pandi

Front Med (Lausanne)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Aggeliki Pandi

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State-of-the-Art Treatments for Sarcoidosis.
Ilias C Papanikolaou, Emmanouil Antonakis, Aggeliki Pandi

Methodist Debakey Cardiovasc J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.
Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Aggeliki Pandi

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.
Konstantinos Pagkratis, Serafeim Chrysikos, Emmanouil Antonakis, Aggeliki Pandi, Chrysavgi Nikolaou Kosti

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab-induced erythema multiforme in a patient with chronic sarcoidosis.
Andreas Afthinos, Aggeliki Pandi, Maria Horti, Ilias C Papanikolaou

Adv Respir Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis